Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04543916
Title Venetoclax and Irinotecan in Relapsed/Refractory SCLC
Recruitment Withdrawn
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Virginia Commonwealth University
Indications

lung small cell carcinoma

Therapies

Irinotecan + Venetoclax

Age Groups: adult | senior
Covered Countries


No variant requirements are available.